Mixed treatment for same‐severe mixed urinary incontinence: A novel method

• Published in: Clinical case reports Vol. 12; no. 3; pp. e8579 - n/a
• Main Authors: Hamidi Alamdari, Daryoush, Douzandeh, Armina, Keshvari Shirvan, Maliheh, Narouie, Behzad, Radpour, Negar
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01-03-2024; Wiley
• Subjects: Abdomen; Biofeedback; Blood; Blood platelets; Botulinum toxin; Case reports; Catheters; Endoscopy; General anesthesia; Intervention; Nocturia; novel treatment; Patients; Pelvis; Plasma; platelet‐rich plasma; Questionnaires; Stem cells; Surgery; treatment efficacy; Urinary incontinence; Urine; Urogenital system; Urology; Vagina; stem cells; novel treatment; platelet‐rich plasma; urinary incontinence; treatment efficacy
• ISSN: 2050-0904; 2050-0904
• DOI: 10.1002/ccr3.8579

Key Clinical Message
Innovative mixed treatment offers hope for persistent mixed urinary incontinence (MUI): PRP‐Fibrin Glue‐Stem Cell injection, Botox, and TVT in a single session. Successful case study reveals promising outcomes, emphasizing the need for further research.
Mixed urinary incontinence is a complaint of stress and urge incontinence which affects patients' quality of life and dramatic changes in patients' physical, mental, and socioeconomic status. The treatment is challenging and depends on the dominance of one of the complaints to the other. The progress in the method of treatment is still under discussion. This study reports treatment of a MUI case in a 56‐year‐old, with a history of MUI of 7‐year duration, which was persistent to pharmacological treatment, pelvic muscle training, biofeedback, and anti‐incontinence surgery (Burch Colposuspension). PRP‐Fibrin Glue‐Stem Cell injection, Botox injection, and TVT were performed in a one surgery session. Patient was discharged with ability to urinate with acceptable amount of post void residue. After 3‐month follow‐up, patient was completely satisfied and happy. Further research is needed to substantiate the efficacy of these mixed treatments for MUI.